The move is expected to cut costs for some patients but faces litigation from the drugmakers and heavy criticism from Republican lawmakers. Original article: https://www.reviewjournal.com/news/politics-and-government/jardiance-eliquis-among-10-drugs-targeted-for-medicare-price-talks-2895569/
